Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

cured notes125,000125,000Capital lease obligations, less current portion6,0258,049Liability related to receipt of refundable milestone payment70,00070,000Liability related to sale of future royalties, less current portion121,431121,520Deferred revenue, less current portion88,91882,384Other long-term liabilities17,76819,256Total liabilities513,497524,430Commitments and contingenciesStockholders' equity (deficit) :Preferred stock--Common stock1211Capital in excess of par value1,776,7461,643,660Accumulated other comprehensive loss(887)(1,181)Accumulated deficit(1,811,231)(1,732,393)Total stockholders' equity (deficit) (35,360)(89,903)Total liabilities and stockholders' equity (deficit) $
478,137
$
434,527
(1) The consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements. NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(I
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...  Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Sawae Technologica Ltda., an X-ray system equipment manufacturer based ... its Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... million, significant healthcare technical advancements and efficiencies are required. ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
(Date:7/2/2015)... 2015   Wilson Therapeutics AB , a privately-held ... to its board of directors. The appointment was approved ... June 30. "We are delighted to welcome ... Hansson , CEO of Wilson Therapeutics. "Hans brings significant ... forward to his contributions to the Company." ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... company Fermiscan,who is using a US synchrotron in ... through the analysis of an individual,s hair, has,demonstrated ... cancer., (Photo: http://www.newscom.com/cgi-bin/prnh/20080619/AQTH082 ), A ... American Medical,Association(1) (US study), showed that breast screening ...
... NASHUA, N.H., June 19 iCAD, Inc. (Nasdaq:,ICAD), ... the early identification of cancer, today announced it ... virtual colonoscopy CAD,product, in partnership with ACR Image ... (ACR). iCAD and ACR Image Metrix, having completed ...
Cached Medicine Technology:New Australian Technology: Detecting Breast Cancer With Hair 2New Australian Technology: Detecting Breast Cancer With Hair 3New Australian Technology: Detecting Breast Cancer With Hair 4iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 2iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 3iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix 4
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader in ... the release and publication of their newest offering to complement the existing line ... , Designed in support of coverage for the full spectrum of Semi ...
(Date:7/2/2015)... ... 02, 2015 , ... Maddock Douglas is an internationally recognized ... To help manage the increasing demand for innovation as a primary growth strategy, ... Strategic Engagements. , Benkendorf is a seasoned management executive with more than 25 ...
(Date:7/1/2015)... , ... July 01, 2015 , ... In the United ... Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, the summer temperatures are ... more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry Spa notes that ...
(Date:7/1/2015)... ... 01, 2015 , ... Dr. Jian-Dong Li, a professor and ... Georgia Research Alliance Eminent Scholar in Inflammation and Immunity, has received a five-year, ... The grant from the National Institute on Deafness and Other Communication Disorders of ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court ... http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to an ... June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer can ...
Breaking Medicine News(10 mins):Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... and vegetables per day is one of the means that ... EPIC study carried out by researchers from 10 countries has ... thing is not just the quantity but also the variety ... to 23%. "This research looks more deeply into ...
... , FRIDAY, Nov. 19 (HealthDay News) ... their choice that they can suffer separation anxiety if ... study suggests. The findings suggest that these consumers ... at the Marshall School of Business at the University ...
... HealthDay Reporter , THURSDAY, Nov. 18 (HealthDay News) -- Knowing ... can help fight the rise of deadly "superbugs," say experts ... About half of antibiotics prescribed are unnecessary or inappropriate, ... don,t respond, or respond less effectively, to the drugs used ...
... (1) suggesting that amyotrophic lateral sclerosis (ALS) may ... collision sports" lacks scientific epidemiological evidence to support ... study, several experts specializing in motor neuron diseases ... clinical merit. Their editorial, which aims to dispel ...
... News) -- The spleen may be a major source of ... site of a spinal cord injury, a new animal study ... to find new treatments for spinal cord injuries, researchers said. ... bone marrow as the source of these inflammation-causing cells called ...
... (November 18, 2010) SAGE has partnered with Division 35 ... of Women Quarterly (PWQ), the official journal of the ... from Wiley-Blackwell to SAGE with the March 2011 issue. ... and men of all national origins, who are interested in ...
Cached Medicine News:Health News:Eating a variety of fruit cuts lung cancer risk 2Health News:Smarten Up About Antibiotics, CDC Urges 2Health News:Smarten Up About Antibiotics, CDC Urges 3Health News:Reports claiming ALS caused by head trauma lacks scientific validation 2Health News:Spleen Cells Tied to Damage of Spinal Cord Injury in Animal Study 2
... With its wide orifice tip, the Finntip ... cell suspensions and macromolecules like genomic DNA. ... causes cell fragmentation. It is excellent for ... the model, the inside diameter of the ...
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
... Each box contains 1000 tips (5 bags of ... (4 bags of 50 tips). Also available in ... pack. Bulk Packs are sealed with a tamper-proof ... access to Gilsons Diamond Tips. Bulk Packs are ...
Medicine Products: